News | July 24, 2007

Coronary CTA Puts Women, Children at Risk of Cancer

July 25, 2007 – Using 64-slice coronary CT angiography as a diagnostic test poses a substantial risk of developing radiation-induced cancer for women and younger patients, according to a study published in the Journal of the American Medical Association earlier this month.

The researcher team, led by Dr. Andrew Einstein, Ph.D., assistant professor of clinical medicine at Columbia University College of Physicians and Surgeons in New York City, estimated the age-specific lifetime attributable cancer risk (LAR) based on age, sex and scan protocol, and found "rather than a relatively constant risk of cancer in 1 person per 1000 to 2000 exposed, the LAR ranged from less than 0.02% to nearly 1%" (JAMA, July 18, 2007, Vol. 293:3, pp. 317-323).

Standard spiral CT protocols, including electrocardiographically controlled tube current modulation (ECTCM), were performed on standardized male and female anthropomorphic mathematical phantoms coupled with the application of Monte Carlo simulations to estimate statistical distribution of dose, and organ doses ranged from 42-91 mSv for the lungs and 50-80 mSv for the female breast.

Results from the study found that lifetime cancer risk estimates for standard cardiac scans came in at 1 in 143 for a 20-year-old woman to 1 in 3,261 for an 80-year-old male. A combined CT scan of the heart and aorta posted higher LARs, up to 1 in 114 for a 20-year-old woman. The estimated cancer risk using ECTCM was 1 in 715 for a 60-year-old woman and 1 in 1,911 for a 60-year-old man. By using ECTCM, the risk estimate for a 20-year-old female decreased to 1 in 219 and to 1 in 5,017 for a 20-year-old male.
Researchers concluded that "risks were particularly high for women in their 20s and decreased markedly as a function of age,” and “the leading cause of cancer in women from a (coronary CTA) scan was breast cancer until 32 years of age, after which lung cancer risk exceeded that of breast cancer."

For more information: jama.ama-assn.org/


Related Content

News | CT Angiography (CTA)

Oct. 27, 2025 — At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting in San Francisco, Royal ...

Home October 30, 2025
Home
News | CT Angiography (CTA)

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of ...

Home October 29, 2025
Home
News | CT Angiography (CTA)

Oct. 22, 2025 — Qure has announced its latest (510) K clearance from the US Food and Drug Administration (FDA). The ...

Home October 23, 2025
Home
News | CT Angiography (CTA)

Sept. 2, 2025 — GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Home September 09, 2025
Home
News | CT Angiography (CTA)

Aug. 11, 2025 — Elucid announced that United Healthcare has updated its cardiac imaging guidelines to align with recent ...

Home August 11, 2025
Home
News | CT Angiography (CTA)

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz ...

Home May 02, 2025
Home
News | CT Angiography (CTA)

May 1, 2025 — A new expert opinion document jointly released by the Society for Cardiovascular Angiography and ...

Home May 01, 2025
Home
Feature | CT Angiography (CTA) | By Melinda Taschetta-Millane

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and ...

Home March 07, 2024
Home
News | CT Angiography (CTA)

January 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary solutions ...

Home January 23, 2024
Home
News | CT Angiography (CTA)

January 11, 2024 — According to the American Journal of Roentgenology (AJR), photon-counting detector (PCD) CT with ...

Home January 11, 2024
Home
Subscribe Now